AstraZeneca PLC is 128.7x more valuable than Day One Biopharmaceuticals, Inc. by market capitalization ($286.27 B vs $2.22 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | DAWN | AZN |
|---|---|---|
| Market cap | $2.22 B | $286.27 B |
| US-listed rank | #2029 | #45 |
| Revenue (latest FY) | $158.18M | - |
| Net income (latest FY) | -$107.32B | - |
| Net margin | -67847.2% | - |
| SEC filings | 493 | 1,004 |
AstraZeneca PLC is 128.7x more valuable than Day One Biopharmaceuticals, Inc. by market capitalization ($286.27 B vs $2.22 B).
Full pages: Day One Biopharmaceuticals, Inc. and AstraZeneca PLC, or browse the full rankings.